Skip to main content

Alagille Syndrome

  • Chapter
  • First Online:
Diseases of the Liver in Children

Abstract

The Alagille syndrome is a multisystem developmental disease caused by mutations in Notch signaling pathway genes; typically JAG1 and very rarely NOTCH2. The syndrome is characterized by a wide variety of affected organs, including liver, heart, kidney, eye, spine, vasculature, and face. Within each organ, there are a range of abnormalities sometimes ranging from trivial to fatal. The most severe end of the spectrum of liver disease in Alagille syndrome is marked by profound cholestasis, with intense pruritus, hypercholesterolemia, xanthomas, jaundice, and fat malabsorption. Liver transplantation is successful at treating and curing the liver disease, but other systemic manifestations persist or progress. The identification of JAG1 as the cause in over 90 % and NOTCH2 in approximately 1 % has led to tremendous advances in understanding the pathogenesis of ALGS and also normal development. Analysis of mutation carriers has greatly expanded the number and the spectrum of Alagille syndrome patients and provided useful precision for family planning.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

JAG1 :

Italicized gene

Notch:

Signaling pathway

Notch:

Receptor

NOTCH2, NOTCH3 :

Italicized gene

References

  1. Alagille D, Gautier M, Habib EC, Dommergues JP. Pre- and postoperative hepatic biopsy data in prolonged cholestasis in infants. Study of 128 cases. Arch Fr Pediatr. 1969;26:283–96.

    PubMed  CAS  Google Scholar 

  2. Alagille D, Odievre M, Gautier M, Dommergues JP. Hepatic ductular hypoplasia associated with characteristic facies, vertebral malformations, retarded physical, mental, and sexual development, and cardiac murmur. J Pediatr. 1975;86:63–71.

    Article  PubMed  CAS  Google Scholar 

  3. Watson GH, Miller V. Arteriohepatic dysplasia: familial pulmonary arterial stenosis with neonatal liver disease. Arch Dis Child. 1973;48:459–66.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  4. Alagille D, Estrada A, Hadchouel M, Gautier M, Odievre M, Dommergues JP. Syndromic paucity of interlobular bile ducts (Alagille syndrome or arteriohepatic dysplasia): review of 80 cases. J Pediatr. 1987;110:195–200.

    Article  PubMed  CAS  Google Scholar 

  5. Crosnier C, Lykavieris P, Meunier-Rotival M, Hadchouel M. Alagille syndrome. The widening spectrum of arteriohepatic dysplasia. Clin Liver Dis. 2000;4:765–78.

    Article  PubMed  CAS  Google Scholar 

  6. Deprettere A, Portmann B, Mowat AP. Syndromic paucity of the intrahepatic bile ducts: diagnostic difficulty; severe morbidity throughout early childhood. J Pediatr Gastroenterol Nutr. 1987;6:865–71.

    Article  PubMed  CAS  Google Scholar 

  7. Emerick KM, Rand EB, Goldmuntz E, Krantz ID, Spinner NB, Piccoli DA. Features of Alagille syndrome in 92 patients: frequency and relation to prognosis. Hepatology. 1999;29:822–9.

    Article  PubMed  CAS  Google Scholar 

  8. Hoffenberg EJ, Narkewicz MR, Sondheimer JM, Smith DJ, Silverman A, Sokol RJ. Outcome of syndromic paucity of interlobular bile ducts (Alagille syndrome) with onset of cholestasis in infancy. J Pediatr. 1995;127:220–4.

    Article  PubMed  CAS  Google Scholar 

  9. Quiros-Tejeira RE, Ament ME, Heyman MB, Martin MG, Rosenthal P, Hall TR, McDiarmid SV, Vargas JH. Variable morbidity in Alagille syndrome: a review of 43 cases. J Pediatr Gastroenterol Nutr. 1999;29:431–7.

    Article  PubMed  CAS  Google Scholar 

  10. Li L, Krantz ID, Deng Y, Genin A, Banta AB, Collins CC, Qi M, Trask BJ, Kuo WL, Cochran J, et al. Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1. Nat Genet. 1997;16:243–51.

    Article  PubMed  CAS  Google Scholar 

  11. Oda T, Elkahloun AG, Pike BL, Okajima K, Krantz ID, Genin A, Piccoli DA, Meltzer PS, Spinner NB, Collins FS, et al. Mutations in the human Jagged1 gene are responsible for Alagille syndrome. Nat Genet. 1997;16:235–42.

    Article  PubMed  CAS  Google Scholar 

  12. Warthen DM, Moore EC, Kamath BM, Morrissette JJ, Sanchez P, Piccoli DA, Krantz ID, Spinner NB. Jagged1 (JAG1) mutations in Alagille syndrome: increasing the mutation detection rate. Hum Mutat. 2006;27:436–43.

    Article  PubMed  CAS  Google Scholar 

  13. Kamath BM, Bauer RC, Loomes KM, Chao G, Gerfen J, Hutchinson A, Hardikar W, Hirschfield G, Jara P, Krantz ID, et al. NOTCH2 mutations in Alagille syndrome. J Med Genet. 2012;49:138–44.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  14. McDaniell R, Warthen DM, Sanchez-Lara PA, Pai A, Krantz ID, Piccoli DA, Spinner NB. NOTCH2 mutations cause Alagille syndrome, a heterogeneous disorder of the notch signaling pathway. Am J Hum Genet. 2006;79:169–73.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  15. Kamath BM, Bason L, Piccoli DA, Krantz ID, Spinner NB. Consequences of JAG1 mutations. J Med Genet. 2003;40:891–5.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  16. Eldadah ZA, Hamosh A, Biery NJ, Montgomery RA, Duke M, Elkins R, Dietz HC. Familial tetralogy of Fallot caused by mutation in the jagged1 gene. Hum Mol Genet. 2001;10:163–9.

    Article  PubMed  CAS  Google Scholar 

  17. Le Caignec C, Lefevre M, Schott JJ, Chaventre A, Gayet M, Calais C, Moisan JP. Familial deafness, congenital heart defects, and posterior embryotoxon caused by cysteine substitution in the first epidermal-growth-factor-like domain of jagged 1. Am J Hum Genet. 2002;71:180–6.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Garg V, Muth AN, Ransom JF, Schluterman MK, Barnes R, King IN, Grossfeld PD, Srivastava D. Mutations in NOTCH1 cause aortic valve disease. Nature. 2005;437:270–4.

    Article  PubMed  CAS  Google Scholar 

  19. Joutel A, Corpechot C, Ducros A, Vahedi K, Chabriat H, Mouton P, Alamowitch S, Domenga V, Cecillion M, Marechal E, et al. Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature. 1996;383:707–10.

    Article  PubMed  CAS  Google Scholar 

  20. Krantz ID, Colliton RP, Genin A, Rand EB, Li L, Piccoli DA, Spinner NB. Spectrum and frequency of jagged1 (JAG1) mutations in Alagille syndrome patients and their families. Am J Hum Genet. 1998;62:1361–9.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  21. Gridley T. Notch signaling in vascular development and physiology. Development. 2007;134:2709–18.

    Article  PubMed  CAS  Google Scholar 

  22. Kamath BM, Thiel BD, Gai X, Conlin LK, Munoz PS, Glessner J, Clark D, Warthen DM, Shaikh TH, Mihci E, et al. SNP array mapping of chromosome 20p deletions: genotypes, phenotypes, and copy number variation. Hum Mutat. 2009;30:371–8.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  23. Kahn E, Markowitz J, Aiges H, Daum F. Human ontogeny of the bile duct to portal space ratio. Hepatology. 1989;10:21–3.

    Article  PubMed  CAS  Google Scholar 

  24. Kahn E. Paucity of interlobular bile ducts. Arteriohepatic dysplasia and nonsyndromic duct paucity. Perspect Pediatr Pathol. 1991;14:168–215.

    PubMed  CAS  Google Scholar 

  25. Kaye AJ, Rand EB, Munoz PS, Spinner NB, Flake AW, Kamath BM. Effect of Kasai procedure on hepatic outcome in Alagille syndrome. J Pediatr Gastroenterol Nutr. 2010;51:319–21.

    PubMed  Google Scholar 

  26. Markowitz J, Daum F, Kahn EI, Schneider KM, So HB, Altman RP, Aiges HW, Alperstein G, Silverberg M. Arteriohepatic dysplasia. I. Pitfalls in diagnosis and management. Hepatology. 1983;3:74–6.

    Article  PubMed  CAS  Google Scholar 

  27. Lykavieris P, Hadchouel M, Chardot C, Bernard O. Outcome of liver disease in children with Alagille syndrome: a study of 163 patients. Gut. 2001;49:431–5.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  28. Cynamon HA, Andres JM, Iafrate RP. Rifampin relieves pruritus in children with cholestatic liver disease. Gastroenterology. 1990;98:1013–6.

    Article  PubMed  CAS  Google Scholar 

  29. Yerushalmi B, Sokol RJ, Narkewicz MR, Smith D, Karrer FM. Use of rifampin for severe pruritus in children with chronic cholestasis. J Pediatr Gastroenterol Nutr. 1999;29:442–7.

    Article  PubMed  CAS  Google Scholar 

  30. Balistreri WF. Bile acid therapy in pediatric hepatobiliary disease: the role of ursodeoxycholic acid. J Pediatr Gastroenterol Nutr. 1997;24:573–89.

    Article  PubMed  CAS  Google Scholar 

  31. Zellos A, Roy A, Schwarz KB. Use of oral naltrexone for severe pruritus due to cholestatic liver disease in children. J Pediatr Gastroenterol Nutr. 2010;51:787–9.

    Article  PubMed  Google Scholar 

  32. Emerick KM, Whitington PF. Partial external biliary diversion for intractable pruritus and xanthomas in Alagille syndrome. Hepatology. 2002;35:1501–6.

    Article  PubMed  Google Scholar 

  33. Whitington PF, Whitington GL. Partial external diversion of bile for the treatment of intractable pruritus associated with intrahepatic cholestasis. Gastroenterology. 1988;95:130–6.

    PubMed  CAS  Google Scholar 

  34. Dingemann C, Baumann U, Petersen C, Lentze MJ, Ure B. Ileal exclusion for intractable pruritus in Alagille syndrome. Eur J Pediatr Surg. 2012;22:251–3.

    Article  PubMed  Google Scholar 

  35. Modi BP, Suh MY, Jonas MM, Lillehei C, Kim HB. Ileal exclusion for refractory symptomatic cholestasis in Alagille syndrome. J Pediatr Surg. 2007;42:800–5.

    Article  PubMed  Google Scholar 

  36. Cardona J, Houssin D, Gauthier F, Devictor D, Losay J, Hadchouel M, Bernard O. Liver transplantation in children with Alagille syndrome – a study of twelve cases. Transplantation. 1995;60:339–42.

    Article  PubMed  CAS  Google Scholar 

  37. Englert C, Grabhorn E, Burdelski M, Ganschow R. Liver transplantation in children with Alagille syndrome: indications and outcome. Pediatr Transplant. 2006;10:154–8.

    Article  PubMed  Google Scholar 

  38. Kasahara M, Kiuchi T, Inomata Y, Uryuhara K, Sakamoto S, Ito T, Fujimoto Y, Ogura Y, Oike F, Tanaka K. Living-related liver transplantation for Alagille syndrome. Transplantation. 2003;75:2147–50.

    Article  PubMed  Google Scholar 

  39. Arnon R, Annunziato R, Miloh T, Suchy F, Sakworawich A, Hiroshi S, Kishore I, Kerkar N. Orthotopic liver transplantation for children with Alagille syndrome. Pediatr Transplant. 2010;14:622–8.

    Article  PubMed  Google Scholar 

  40. Kamath BM, Yin W, Miller H, Anand R, Rand EB, Alonso E, Bucuvalas J. Outcomes of liver transplantation in Alagille syndrome: the split experience. Liver Transpl. 2012;18(8):940–8.

    Article  PubMed  Google Scholar 

  41. Hori T, Egawa H, Takada Y, Oike F, Kasahara M, Ogura Y, Sakamoto S, Ogawa K, Yonekawa Y, Nguyen JH, et al. Long-term outcomes after living-donor liver transplantation for Alagille syndrome: a single center 20-year experience in Japan. Am J Transplant. 2010;10:1951–2.

    Article  PubMed  CAS  Google Scholar 

  42. Gurkan A, Emre S, Fishbein TM, Brady L, Millis M, Birnbaum A, Kim-Schluger L, Sheiner PA. Unsuspected bile duct paucity in donors for living-related liver transplantation: two case reports. Transplantation. 1999;67:416–8.

    Article  PubMed  CAS  Google Scholar 

  43. Kamath BM, Schwarz KB, Hadzic N. Alagille syndrome and liver transplantation. J Pediatr Gastroenterol Nutr. 2010;50:11–5.

    Article  PubMed  Google Scholar 

  44. Razavi RS, Baker A, Qureshi SA, Rosenthal E, Marsh MJ, Leech SC, Rela M, Mieli-Vergani G. Hemodynamic response to continuous infusion of dobutamine in Alagille’s syndrome. Transplantation. 2001;72:823–8.

    Article  PubMed  CAS  Google Scholar 

  45. McElhinney DB, Krantz ID, Bason L, Piccoli DA, Emerick KM, Spinner NB, Goldmuntz E. Analysis of cardiovascular phenotype and genotype-phenotype correlation in individuals with a JAG1 mutation and/or Alagille syndrome. Circulation. 2002;106:2567–74.

    Article  PubMed  Google Scholar 

  46. Kamath BM, Spinner NB, Rosenblum ND. Renal involvement and the role of Notch signalling in Alagille syndrome. Nat Rev Nephrol. 2013;9:409–18.

    Article  PubMed  CAS  Google Scholar 

  47. Kamath BM, Podkameni G, Hutchinson AL, Leonard LD, Gerfen J, Krantz ID, Piccoli DA, Spinner NB, Loomes KM, Meyers K. Renal anomalies in Alagille syndrome: a disease-defining feature. Am J Med Genet A. 2011;158A(1):85–9.

    Article  PubMed  Google Scholar 

  48. Lykavieris P, Crosnier C, Trichet C, Meunier-Rotival M, Hadchouel M. Bleeding tendency in children with Alagille syndrome. Pediatrics. 2003;111:167–70.

    Article  PubMed  Google Scholar 

  49. Emerick KM, Krantz ID, Kamath BM, Darling C, Burrowes DM, Spinner NB, Whitington PF, Piccoli DA. Intracranial vascular abnormalities in patients with Alagille syndrome. J Pediatr Gastroenterol Nutr. 2005;41:99–107.

    Article  PubMed  Google Scholar 

  50. Kamath BM, Spinner NB, Emerick KM, Chudley AE, Booth C, Piccoli DA, Krantz ID. Vascular anomalies in Alagille syndrome: a significant cause of morbidity and mortality. Circulation. 2004;109:1354–8.

    Article  PubMed  Google Scholar 

  51. Kamath BM, Loomes KM, Oakey RJ, Emerick KE, Conversano T, Spinner NB, Piccoli DA, Krantz ID. Facial features in Alagille syndrome: specific or cholestasis facies? Am J Med Genet. 2002;112:163–70.

    Article  PubMed  Google Scholar 

  52. Kamath BM, Loomes KM, Oakey RJ, Krantz ID. Supernumerary digital flexion creases: an additional clinical manifestation of Alagille syndrome. Am J Med Genet. 2002;112:171–5.

    PubMed  Google Scholar 

  53. Bales CB, Kamath BM, Munoz PS, Nguyen A, Piccoli DA, Spinner NB, Horn D, Shults J, Leonard MB, Grimberg A, et al. Pathologic lower extremity fractures in children with Alagille syndrome. J Pediatr Gastroenterol Nutr. 2010;51(1):66–70.

    Article  PubMed  PubMed Central  Google Scholar 

  54. Rennie CA, Chowdhury S, Khan J, Rajan F, Jordan K, Lamb RJ, Vivian AJ. The prevalence and associated features of posterior embryotoxon in the general ophthalmic clinic. Eye (Lond). 2005;19:396–9.

    Article  CAS  Google Scholar 

  55. Hingorani M, Nischal KK, Davies A, Bentley C, Vivian A, Baker AJ, Mieli-Vergani G, Bird AC, Aclimandos WA. Ocular abnormalities in Alagille syndrome. Ophthalmology. 1999;106:330–7.

    Article  PubMed  CAS  Google Scholar 

  56. Nischal KK, Hingorani M, Bentley CR, Vivian AJ, Bird AC, Baker AJ, Mowat AP, Mieli-Vergani G, Aclimandos WA. Ocular ultrasound in Alagille syndrome: a new sign. Ophthalmology. 1997;104:79–85.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to David A. Piccoli MD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this chapter

Cite this chapter

Kamath, B.M., Piccoli, D.A. (2014). Alagille Syndrome. In: Murray, K., Horslen, S. (eds) Diseases of the Liver in Children. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-9005-0_11

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-9005-0_11

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-9004-3

  • Online ISBN: 978-1-4614-9005-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics